Recherche
Enseignement
Solutions
S'identifier
FR
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Oncology R&D group
Jonathon Golas has not added Biography.
If you are Jonathon Golas and would like to personalize this page please email our Author Liaison for assistance.
Epigenetic reprogramming by tumor-derived EZH2 gain-of-function mutations promotes aggressive 3D cell morphologies and enhances melanoma tumor growth.
Oncotarget Feb, 2015 | Pubmed ID: 25671303
Cancer-associated fibroblasts suppress SOX2-induced dysplasia in a lung squamous cancer coculture.
Proceedings of the National Academy of Sciences of the United States of America 12, 2018 | Pubmed ID: 30487219
Pfizer Worldwide Research and Development
Shuang Chen1,
Andreas Giannakou1,
Jonathon Golas1,
Kenneth G. Geles1
1Oncology R&D group, Pfizer Worldwide Research and Development
Confidentialité
Conditions d'utilisation
Politiques
Contactez-nous
RECOMMANDER À LA BIBLIOTHÈQUE
NEWSLETTERS JoVE
JoVE Journal
Collections de méthodes
JoVE Encyclopedia of Experiments
Archives
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centre de ressources universitaires
Auteurs
Bibliothécaires
Accès
À PROPOS DE JoVE
Copyright © 2024 MyJoVE Corporation. Tous droits réservés.
